Compare ETON & AROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ETON | AROW |
|---|---|---|
| Founded | 2017 | 1851 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 510.1M | 529.9M |
| IPO Year | 2018 | 1995 |
| Metric | ETON | AROW |
|---|---|---|
| Price | $23.04 | $33.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $39.33 | $28.00 |
| AVG Volume (30 Days) | ★ 337.4K | 77.9K |
| Earning Date | 03-19-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.73% |
| EPS Growth | N/A | ★ 49.72 |
| EPS | N/A | ★ 2.65 |
| Revenue | ★ $79,950,000.00 | N/A |
| Revenue This Year | $34.30 | $17.58 |
| Revenue Next Year | $36.43 | $5.21 |
| P/E Ratio | ★ N/A | $12.11 |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $11.09 | $22.72 |
| 52 Week High | $23.00 | $36.44 |
| Indicator | ETON | AROW |
|---|---|---|
| Relative Strength Index (RSI) | 75.33 | 52.86 |
| Support Level | $16.23 | $31.06 |
| Resistance Level | N/A | $34.57 |
| Average True Range (ATR) | 1.13 | 0.88 |
| MACD | 0.53 | 0.04 |
| Stochastic Oscillator | 86.94 | 81.12 |
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services, including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of the company's revenue is interest income, fees, commission earned through its subsidiaries.